secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0000950170-23-011424
Event type: leadership
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director John Canan resigns from Acasti Pharma board, no dispute
----------------------------------------------------------------

- Jean-Marie (John) Canan resigned from the board effective March 30, 2023.
- Canan was a member of the audit committee and governance and human resources committee.
- Resignation was not due to any dispute or disagreement with the Company or board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000095017023011424/0000950170-23-011424-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000095017023011424/acst-20230330.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-011424

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer